The largest database of trusted experimental protocols

16 protocols using faf bsa

1

Purification and Radiolabeling of CVA9 Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
One microgram of unlabeled, purified CVA9 was mixed with 1 to 3 μL of 35S-labeled CVA9 (demonstrating ~1,000 cpm), and faf-BSA (Sigma-Aldrich) or buffer, giving final concentrations as indicated in Table 1, was added to obtain a final volume of 100 μL. For molar ratio calculations between the pocket, faf-BSA, and palmitate (Sigma-Aldrich), an estimated molecular weight of 8 MDa was used for CVA9 and the weights provided by the supplier were used for faf-BSA and palmitate. Samples were incubated at 37°C for 1 h (faf-BSA treatment) or 3 h (ion treatment) before gradient separation. The control samples (purified CVA9 in storage buffer) (Table 1) were kept on ice during the incubations. After the incubation, the samples were pipetted on top of linear 5-to-20% sucrose gradients prepared in R-buffer and centrifuged (SW41, 35,000 rpm, 2 h, 4°C). After centrifugation, 500-μL fractions were collected and mixed with scintillation cocktail (Ultima Gold MW; PerkinElmer), and the radioactivity of each fraction was measured (Tri-Carb 2910 TR; PerkinElmer).
+ Open protocol
+ Expand
2

Oxidative and Lipotoxic Stress in C2C12 Myoblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse C2C12 myoblasts (ATCC, Manassas, VA, USA) were cultured in growth medium containing 25 mM glucose Dulbecco’s Modified Eagle Medium (DMEM) and 10% fetal bovine serum (FBS) (Life Technologies, Mulgrave, VIC, AUS) at 37 °C in 5% CO2. To differentiate cells, differentiation medium consisting of 2% horse serum and 25 mM glucose DMEM was added when cells were confluent and refreshed every 48 h. Platinum-E (Plat-E) cells (Jomar Bioscience, Welland, SA, AUS) were used for the production of retrovirus and were cultured in growth medium at 37 °C in 5% CO2. To induce oxidative stress, myoblasts were treated with 0.5 mM hydrogen peroxide (H2O2; Sigma–Aldrich, St. Louis, MO, USA) in 10% FBS DMEM for 4 or 8 h. For lipotoxic treatments, PA (Sigma–Aldrich, P0500) was dissolved in 100% ethanol and conjugated for 1 h at 37 °C with gentle rotation with 10% fatty acid-free bovine serum albumin (FAF-BSA, Sigma–Aldrich) in serum-free DMEM at a final concentration of 4.5 mM PA and 1.5 mM FAF-BSA (3:1 ratio). The equivalent amount of 100% ethanol was added to 10% FAF-BSA/DMEM as a vehicle control treatment. C2C12 myoblasts were treated with 0.5 mM PA conjugated with FAF-BSA or with vehicle control for 8 or 16 h in 10% FBS DMEM.
+ Open protocol
+ Expand
3

Astrocyte Activation and Secretome Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After reaching confluence, glial monolayers were washed three times with serum-free DMEM/F12 medium and incubated as previously described for an additional day in this medium. After this period, the cultures were treated with 1 μM LPA (Spohr et al., 2011 (link)) (Avanti Polar Lipids, Alabaster, AL, USA) in DMEM/F12 supplemented with 0.1% fatty-acid-free bovine serum albumin (FAFBSA, Sigma Chemical Co.) for 4 h. Control astrocyte carpets were treated with DMEM/F12 supplemented with 0.1% FAFBSA. Then, the glial monolayers were washed with serum-free DMEM/F12 medium, and the medium was replaced by DMEM/F12 without serum and used as the substrate in neural progenitor–astrocyte assays. For astrocyte conditioned medium preparation, after the astrocyte monolayers were treated with LPA-FAFBSA or FAFBSA, the medium was replaced by DMEM-F12 and the cultures were then maintained for an additional day. Conditioned medium (CM) derived from either LPA-treated astrocytes (LPA-CM) or conditioned medium of control astrocytes (C-CM) was recovered, centrifuged at 1500 g for 10 min, and used immediately or stored in aliquots at −70°C for further use.
+ Open protocol
+ Expand
4

Preparation of Palmitic Acid-BSA Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study uses the fatty acid preparation method of Cousin [19 (link)]. Stock 5mM PA/fatty acid-free bovine serum albumin (FAF-BSA) was prepared as follows. 100 mM PA (Sigma Aldrich, Saint Louis, MO, USA) stock solution was dissolved in 0.1 M NaOH and heated at 70 °C in a water bath. Simultaneously, a 10% (wt/vol) fatty acid-free FAF-BSA (EMD Millipore Corp, Billerica, MA, USA) solution was prepared in deionized H2O in a 55 °C water bath. To prepare a 5 mM PA/10% FAF-BSA stock solution, 0.5 mL of the 100 mM PA was added to 9.5 mL 10% BSA solution, which was then heated at 55 °C in a shaking water bath for 10 min before it was vortex-mixed for 10 s and then incubated for an additional 10 min in a 55 °C water bath. The PA/FAF-BSA complex solution was cooled to room temperature before being sterile filtered using a 0.45 μm pore size filter. Control for this complex was prepared the same way by using just regular BSA (GE Healthcare Life Sciences, GE Healthcare Life Sciences, South Logan, UT, U.S.A). The prepared 5 mM PA/FAF-BSA and regular BSA aliquoted solutions were stored at −20°C, where they were stable for three weeks. The stored PA/FAF-BSA and its control stock solutions were heated for 15 min at 55 °C and cooled to room temperature before the study.
+ Open protocol
+ Expand
5

ARPE-19 Cells Respond to High Glucose and DHA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human retinal pigment epithelium (RPE) cells (ARPE-19) were purchased from the American Type Cell Culture (ATCC–CRL–2302, Manassas, VA, USA) and cultured in Advanced DMEM/F12 basal medium (Thermo Fisher Scientific, Inc., Waltham, MA, USA), supplemented with 20% fetal calf serum (FCS, Merck Life Science S.r.l., Milano, Italy) and 100 U/mL penicillin–streptomycin (Gibco™, Thermo Fisher Scientific, Inc., Waltham, MA, USA), with physiological glucose levels (5 mM). During growth, cells were maintained in a humidified environment (5% CO2). Further sub-cultures of cells (passage number 12) were performed at the proper density in accordance with each experimental method. To investigate the effect of the high glucose concentrations on ARPE-19 metabolism, cultured cells were treated as previously reported [25 (link)]. A 50 mM concentration of D-Glucose was added to cells for 20 h, followed by the administration of docosahexaenoic acid (DHA) for a further 16 h (Cayman Chemical, Ann Arbor, Michigan, MI, USA—50 mg in 200 µL ethanol), and this was then complexed to fatty acid-free bovine serum albumin (FAF-BSA, Merck Life Science S.r.l., Milano, Italy), prior to use as described [28 (link)], to reach the final concentration of 60 µM of DHA.
+ Open protocol
+ Expand
6

Preparation of Palmitic Acid Stock Solution

Check if the same lab product or an alternative is used in the 5 most similar protocols
A stock solution of PA (Sigma, St. Louis, MO, USA) was prepared by conjugating PA with fatty acid-free bovine serum albumin (FAF-BSA, Sigma), as reported previously [21 ]. In brief, PA was dissolved in Dulbecco's Phosphate-Buffered Saline (DPBS; Welgene Inc., Daegu, Korea) at 60°C for 20 min to make a 20 mM stock solution, and the pH was adjusted to 7.0~7.4 with 1 M NaOH. FAF-BSA was dissolved in DPBS. Next, 20 mM PA solution was diluted in 5% FAF-BSA solution at a ratio of 1:3 (v/v) to generate a 5 mM PA stock solution. Next, PA was diluted in a culture medium to make a 100 μM PA working solution. An 0.08% FAF-BSA solution was used as a control.
+ Open protocol
+ Expand
7

Ceramide Signaling Pathway Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI 1640 medium was purchased from Corning (NY, USA; #10-040-CV), DMEM medium from ThermoFisher Scientific Inc. (CA, USA). C16:0 ceramide-1-phosphate (#860533) was obtained from Avanti Polar Lipid (AL, USA), D-erythro-Sphingosine (#SC-3546) from Santa Cruz Biotechnology (TX, USA). Dynabeads M-270 Epoxy Co-IP Kit (#14321D) and OPTIMEM (#31985-062) were acquired from ThermoFisher Scientific Inc. (CA, USA). Fatty acid free (FAF)-BSA (#A6003), Anti-FLAG M2 Affinity Gel (#A2220) and FLAG peptide (#F3290) were purchased from Sigma-Aldrich (MO, USA, #SAB2701099) and Fugene 6 transfection reagent (#E2692) from Promega Corp. (WI, USA).
The following antibodies were used: Anti-SMPDL3b (GenWay Biotech, CA, USA, #GWB-2281D4), Anti-CERK (Sigma-Aldrich, MO, USA, #SAB2701099) and IgG (Sigma-Aldrich, MO, USA #I5381). Anti-ACER2 (#LS-C354506), Anti-SPTLC3 (#LS-C397341), Anti-S1PR1 (#LS-B6370), Anti-SMPD1 (#LS-C334919) antibodies were purchased from LifeSpan BioSciences, Inc. (WA, USA). Secondary antibodies, Anti-Rabbit HRP conjugate (#W401B) and Anti-Mouse HRP conjugate (#W402B) were purchased from Promega Corp. (WI, USA).
+ Open protocol
+ Expand
8

Neuro-2a Cell Response to Lipid Stimuli

Check if the same lab product or an alternative is used in the 5 most similar protocols
All live cell imaging was conducted on a microscope equipped with a heated stage at 37˚C and 5% CO2 on a Nikon A1R microscope (Nikon Instruments Inc., Melville, NY). Confocal images were acquired on a Zeiss 780 LSM confocal microscope (Carl Zeiss, Thornwood, NY).
Neuro-2a cells transfected with either EGFP or EGFP-PLPPR1 were serum starved for 16 h after serial washing with warmed DMEM by incubating cells in DMEM without FBS and then treated with fatty-acid free bovine serum albumin (FAFBSA, Sigma Aldrich cat # 126609), or lysophosphatidic acid (LPA, Cayman Chemical, Ann Arbor, MI cat # 10010093) diluted in FAFBSA. Time lapse images were acquired on a Nikon A1R microscope with a 20×/0.75 dry objective lens with no time delay between frames for 20 min. Cell response was calculated as percentage of the total transfected cell count that retracted their neurites or underwent cell rounding as assessed by an unblinded observer.
+ Open protocol
+ Expand
9

Isolation of Salmon Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatocytes were prepared as described previously53 (link), with minor modifications. Liver from three each of WT and elovl2 KO salmon per dietary treatment was dissected, quickly perfused via hepatic vein, finely chopped and incubated with 20 ml of Solution A; Hank’s balanced salt solution supplemented with 10 mM Hepes, 1 mM EDTA and 1 mg ml−1 collagenase (Sigma, Missouri, USA) for 45 min at 20 °C. Digested tissues were filtered through 100 μm cell strainer (Sigma) and the cells collected by centrifugation at 400 × g for 3 min. The cell pellet was washed with 20 ml of solution A containing 10 mg ml−1 fatty acid free bovine serum albumin, FAF-BSA (Sigma). Thereafter, the cell pellet was washed with 20 ml freshly prepared solution B (calcium free minimum essential medium supplemented with 100 U/ml Penicillin, 100 μg/ml Streptomycin, 0.25 µg/ml Amphotericin B and pH adjusted to 7.1–7.4 by sodium bicarbonate). The cells were further purified by centrifuging at 400 × g for 30 min on top of 54% percoll solution. The hepatocytes layer were collected and washed twice with solution B.
+ Open protocol
+ Expand
10

Conjugation of Palmitic Acid to BSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
PA (Sigma, P9767) was conjugated to fatty acid free bovine serum albumin (FAF-BSA; Sigma, A0281). PA (51.2 mg) was dissolved in 10 ml DPBS at 60°C for 20 min to make a 20 mM stock solution, and the pH was adjusted with 1 M NaOH. FAF-BSA was dissolved in DPBS and sterilized by filtering through a sterile membrane filter. PA (20 mM) was complexed in a 1 to 3 molar ratio with 5% FAF-BSA to generate a 5 mM PA stock solution, and then PA was diluted in RPMI-1640 medium to make a 0.4 mM PA working solution. 0.3% FAF-BSA media was used as a control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!